232 related articles for article (PubMed ID: 23849459)
21. Prophylactic thyroidectomy in multiple endocrine neoplasia 2 (MEN2) patients with the C634Y mutation: A long-term follow-up in a large single-center cohort.
Febrero B; Rodríguez JM; Ríos A; Segura P; Pérez-Sánchez B; Torregrosa N; Hernández AM; Parrilla P
Eur J Surg Oncol; 2019 Apr; 45(4):625-630. PubMed ID: 30366876
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.
Skinner MA; Moley JA; Dilley WG; Owzar K; Debenedetti MK; Wells SA
N Engl J Med; 2005 Sep; 353(11):1105-13. PubMed ID: 16162881
[TBL] [Abstract][Full Text] [Related]
23. Presymptomatic genetic screening in families with multiple endocrine neoplasia type 2.
Frilling A; Höppner W; Eng C; Mulligan L; Raue F; Broelsch CE
J Mol Med (Berl); 1995 May; 73(5):229-33. PubMed ID: 7670926
[TBL] [Abstract][Full Text] [Related]
24. The synergy of germline C634Y and V292M RET mutations in a northern Chinese family with multiple endocrine neoplasia type 2A.
Yang Z; Qi X; Gross N; Kou X; Bai Y; Feng Y; Wang B; Zafereo ME; Li G; Sun C; Li H; Chen X; Huang Z
J Cell Mol Med; 2020 Nov; 24(22):13163-13170. PubMed ID: 32989896
[TBL] [Abstract][Full Text] [Related]
25. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
Hinze R; Holzhausen HJ; Gimm O; Dralle H; Rath FW
Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
[TBL] [Abstract][Full Text] [Related]
26. Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening.
Morris LF; Waguespack SG; Edeiken-Monroe BS; Lee JE; Rich TA; Ying AK; Warneke CL; Evans DB; Perrier ND; Grubbs EG
Ann Surg Oncol; 2013 Jan; 20(1):53-9. PubMed ID: 22890595
[TBL] [Abstract][Full Text] [Related]
27. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?
Calva D; O'Dorisio TM; Sue O'Dorisio M; Lal G; Sugg S; Weigel RJ; Howe JR
Ann Surg Oncol; 2009 Aug; 16(8):2237-44. PubMed ID: 19472011
[TBL] [Abstract][Full Text] [Related]
28. Very early prophylactic thyroid surgery for infants with a mutation of the RET proto-oncogene at codon 634: evaluation of the implementation of international guidelines for MEN type 2 in a single centre.
Piolat C; Dyon JF; Sturm N; Pinson S; Bost M; Jouk PS; Plantaz D; Chabre O
Clin Endocrinol (Oxf); 2006 Jul; 65(1):118-24. PubMed ID: 16817830
[TBL] [Abstract][Full Text] [Related]
29. Medullary thyroid carcinoma.
Pacini F; Castagna MG; Cipri C; Schlumberger M
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
[TBL] [Abstract][Full Text] [Related]
30. Current surgical management in RET mutation carriers [Aktualne postępowanie chirurgiczne u nosicieli mutacji proto-onkogenu RET].
Czarniecka A; Oczko-Wojciechowska M; Hajduk A; Zeman M; Jarzab B
Endokrynol Pol; 2019; 70(4):367-379. PubMed ID: 31489961
[TBL] [Abstract][Full Text] [Related]
31. Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives.
Wang J; Zhang B; Liu W; Zhang Y; Di X; Yang Y; Yan D
Fam Cancer; 2016 Jan; 15(1):99-104. PubMed ID: 26254625
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcome of "prophylactic therapy" for familial medullary thyroid cancer.
Schellhaas E; König C; Frank-Raue K; Buhr HJ; Hotz HG
Surgery; 2009 Nov; 146(5):906-12. PubMed ID: 19744457
[TBL] [Abstract][Full Text] [Related]
33. Prophylactic thyroidectomies in MEN2 syndrome: Management and outcomes.
Bussières V; Roy S; Deladoey J; Rousseau É; St-Vil D; Piché N
J Pediatr Surg; 2018 Feb; 53(2):283-285. PubMed ID: 29336779
[TBL] [Abstract][Full Text] [Related]
34. Characterization of V804M-mutated RET proto-oncogene associated with familial medullary thyroid cancer, report of the largest Turkish family.
Basaran MN; Tuna MM; Karakılıç E; Doğan BA; İmga NN; Berker D; Güler S
J Endocrinol Invest; 2015 May; 38(5):541-6. PubMed ID: 25501606
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes.
Wells SA; Skinner MA
Exp Clin Endocrinol Diabetes; 1998; 106(1):29-34. PubMed ID: 9516056
[TBL] [Abstract][Full Text] [Related]
36. Impact of RET Screening on the Management of Multiple Endocrine Neoplasia Type 2A: 10 Years Experience and Follow-Up in Three Families.
Wang YP; Li FP; Wang HH; Fang XD; Zhu ZS; Chen YL; Qi XP
Endocr Metab Immune Disord Drug Targets; 2022; 22(3):339-347. PubMed ID: 34445950
[TBL] [Abstract][Full Text] [Related]
37. Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey.
Aydoğan Bİ; Yüksel B; Tuna MM; Navdar Başaran M; Akkurt Kocaeli A; Ertörer ME; Aydın K; Güldiken S; Şimşek Y; Cihan Karaca Z; Yılmaz M; Aktürk M; Anaforoğlu İ; Kebapçı N; Duran C; Taşlıpınar A; Kulaksızoğlu M; Gürsoy A; Dağdelen S; Erdoğan MF
J Clin Res Pediatr Endocrinol; 2016 Mar; 8(1):13-20. PubMed ID: 26758973
[TBL] [Abstract][Full Text] [Related]
38. Clinical and oncological features of children and young adults with multiple endocrine neoplasia type 2A.
Puñales MK; da Rocha AP; Meotti C; Gross JL; Maia AL
Thyroid; 2008 Dec; 18(12):1261-8. PubMed ID: 18991485
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcome after DNA-based prophylactic neck surgery in children at risk of hereditary medullary thyroid cancer.
Machens A; Dralle H
Best Pract Res Clin Endocrinol Metab; 2019 Aug; 33(4):101274. PubMed ID: 31043326
[TBL] [Abstract][Full Text] [Related]
40. Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a.
Heizmann O; Haecker FM; Zumsteg U; Müller B; Oberholzer M; Oertli D
Eur J Surg Oncol; 2006 Feb; 32(1):98-102. PubMed ID: 16325365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]